Lead Medical Director, Product Development, Hematology

Genentech, Inc.

Stevenage

Sur place

GBP 160 000 - 297 000

Plein temps

Il y a 3 jours
Soyez parmi les premiers à postuler

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Avantages offerts par ce poste

Discretionary annual bonus

Résumé du poste

Genentech, Inc. is seeking a Board Certified/Board Eligible MD/PhD oncologist to lead late-stage clinical development strategy (Phase II-III) and support regulatory filings. The role requires >5 years of post-graduate clinical/research experience and >3 years in biopharma clinical development, with strong data interpretation and scientific writing skills.

On-site in Boston, SF, Basel, or Welwyn. You will collaborate with cross-functional teams and external partners to advance CDP components, KOL

Qualifications

  • MD/MBBS or MD(MBBS)/PhD in Oncology & Hematology.
  • 5+ years post-grad clinical/scientific research and/or clinical trial experience.
  • 3+ years in biopharmaceutical clinical development with late-stage experience.
  • 3+ years medical monitoring in life sciences.
  • 2+ years engaging with clinical sites, PIs, KOLs.
  • Strong understanding of Phase II-III drug development and related trials.

Responsabilités

  • Support the Clinical Development Plan (CDP) for assigned molecule(s)/indication(s).
  • Collaborate with internal/external partners across multiple functions to align CD strategy and plans.
  • Provide clinical science input for regulatory submissions and regulatory documentation.
  • Review and contribute to Phase I–III protocols and development plans.
  • Track study progress, communicate issues, and suggest mitigation strategies.

Connaissances

Medical monitoring
Clinical development
Data analysis
Scientific writing
KOL engagement
Cross-functional collaboration
Regulatory submissions
Communication skills

Formation

MD/PhD

Description du poste

Who You
Are: (Required)

The PositionRoche's Clinical Development organization is structured by therapeutic area and is responsible for developing and executing the late development (Phase II - III) clinical strategies and plans that deliver medically-differentiated therapies that provide meaningful improvement to Lead Medical Director leads or makes major contributions to development of the Clinical Development (CD) strategy and plan and is responsible for effective and efficient execution for the assigned molecule(s)/indication(s). You will support the development and implementation of the Clinical Development Plan (CDP) for assigned molecule(s)/indication(s); gathering and analyzing data and information necessary to create the CD plan.You will collaborate with a variety of internal/external partners & stakeholders, as well as multidisciplinary internal groups, including business development, research, commercial, legal, etc.You may participate in meetings, reviews, discussions and other interactions regarding early development/Phase I studies to provide clinical science input & guidance; including reviewing and providing late stage input to Phase I & II protocols.You have a demonstrated understanding of Phase II - III drug development.You will take an active role with other CST members, regulatory and other internal partners/stakeholders in the completion and submission of regulatory filings and other regulatory documentation. Provides clinical science information and input for regulatory submissions and other regulatory processes. You will be responsible to ensure strategic and operational alignment of the CDP with the relevant CD strategy, strategic and annual LCP; you will work with other CST members and relevant sub-teams to develop CDP components (e.g., analytics/data strategy, KOL development, publications strategy, etc.)This position is based on-site in Boston, MA (US), San Francisco, CA (US), Basel, CH or Welwyn, UK.Relocation support will not be provided for this position.

You are a Board Certified/Board Eligible (or its equivalent) MD (MBBS), MD(MBBS)/PhD physician in Oncology & HematologyYou have 5+ years of post-grad relevant clinical/scientific research and/or clinical trial experience; You have 3 or more years of experience in biopharmaceutical clinical development with experience in late stage drug development.You have 3+ years of medical monitoring experience within the life sciences space; you are able to support the senior team members with this responsibility.You have 2+ years of experience engaging with clinical sites, PIs, KOLs etcYou have a solid understanding of Phase II - III drug development (e.g trials across different stages of development, or formal education/qualifications in pharmaceutical medicine or drug development); have made significant contributions to an organization's drug development (whether at Roche or another organization); have identified and created clinical development strategies that have led to label-enabling outcomes You have demonstrated the ability to foster and promote a highly productive and inclusive team-based culture in fast-paced clinical and/or research settingsYou have significant experience working with the principles and techniques of data analysis, interpretation and clinical relevance, and demonstrated experience in scientific writing (e.g. manuscripts, grants, scientific protocols, health authority documents)You have demonstrated communication skills in both long-form scientific presentation and short-form communication of complex scientific topics Preferred: Your disease area of focus is Lymphoma.You have strong interpersonal skills: Outstanding interpersonal, verbal, and written communication and influencing skills: have built and cultivated important relationships both inside an organization and externallyYou have the ability to collaborate with relevant team members to measure and monitor study progress against objectives and plans

including any variances, and proactively communicate any issues, challenges and potential strategies to resolveYou have demonstrated experience working with various clinical trial designs, including outcome trials.You have sound knowledge of the pharma/biotech industry, the multiple functions and roles involved in the drug development process.The expected salary range for this position based on the primary location of Boston, MA is $213,000 - $396,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below.BenefitsGenentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Head, Oncology Clinical Development - ADCs
Head, Oncology Clinical Development - ADCs

GSK plc • Greater London

Hybride
GBP 182 000 - 303 000
Vice President - Oncology Clinical Development, Disease Area Head- Hematology
Vice President - Oncology Clinical Development, Disease Area Head- Hematology

GSK plc • Greater London

Hybride
GBP 256 000 - 426 000
Medical Director-Oncology Clinical Development - Gi
Medical Director-Oncology Clinical Development - Gi

Gsk • Stevenage, Cambridge

Hybride
GBP 167 000 - 279 000
Global Head of Biostatistics
Global Head of Biostatistics

Genentech • Welwyn

Sur place
GBP 251 948 - 330 682
Relocation assistance
Annual discretionary bonus
Comprehensive benefits package
Senior Medical Director, Hematology Product Development
Senior Medical Director, Hematology Product Development

Genentech, Inc. • Stevenage

Sur place
GBP 160 000 - 297 000
Discretionary annual bonus
Director, Global Clinical Physician Late HOCT
Director, Global Clinical Physician Late HOCT

0131 BMS Business Services Ltd • Uxbridge

Sur place
GBP 140 000 - 190 000
Medical Monitor (Md)
Medical Monitor (Md)

F. Hoffmann-La Roche AG • Welwyn

Sur place
GBP 180 000 - 240 000
Senior Director, Global Clinical Development (GI Oncology)
Senior Director, Global Clinical Development (GI Oncology)

Bristol-Myers Squibb Co • Uxbridge

Hybride
GBP 150 000 - 190 000
Senior Director, Global Clinical Development (GI Oncology)
Senior Director, Global Clinical Development (GI Oncology)

Bristol Myers Squibb • Denham

Hybride
GBP 150 000 - 210 000
Vice President - Oncology Clinical Development, Disease Area Head- Hematology
Vice President - Oncology Clinical Development, Disease Area Head- Hematology

GSK • Stevenage

Hybride
GBP 180 000 - 240 000